Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 17, 2026
Statin therapy and outcomes in heart failure with mildly reduced ejection fractionAlexander Schmitt, Michael Behnes, Marielen Reinhardt, et al.
Journal of Clinical Medicine|September 14, 2024
Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection FractionMarielen Reinhardt, Tobias Schupp, Michael Behnes, et al.
International Journal of Cardiology|July 30, 2024
Left ventricular diastolic dysfunction in patients with heart failure with mildly reduced ejection fractionNoah Abel, Tobias Schupp, Alexander Schmitt, et al.
Pragmatic and Observational Research|March 14, 2024
Obesity Paradox in Heart Failure with Mildly Reduced Ejection FractionMarielen Reinhardt, Tobias Schupp, Mohammad Abumayyaleh, et al.
European Heart Journal. Acute Cardiovascular Care|November 11, 2023
Prognostic impact of acute decompensated heart failure in patients with heart failure with mildly reduced ejection fractionAlexander Schmitt, Tobias Schupp, Marielen Reinhardt, et al.
International Journal of Cardiology|December 11, 2025
Platelet counts and prognosis in heart failure with mildly reduced ejection fraction: Results from a large-scaled registryJonas Dudda, Michael Behnes, Kathrin Weidner, et al.
European Journal of Clinical Investigation|April 10, 2024
Effect of anaemia and iron deficiency in heart failure with mildly reduced ejection fractionTobias Schupp, Kathrin Weidner, Marielen Reinhardt, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 5, 2025
Predictors and prognosis of progression of aortic valve stenosis in patients hospitalized with heart failure with mildly reduced ejection fractionNoah Abel, Michael Behnes, Alexander Schmitt, et al.
Journal of Clinical Medicine|May 13, 2026
Prognostic Impact of Carvedilol vs. Metoprolol on Long-Term Outcomes in Patients with Heart Failure and Mildly Reduced Ejection FractionKathrin Weidner, Michael Behnes, Marielen Reinhardt, et al.
Frontiers in Cardiovascular Medicine|April 10, 2026
Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fractionKathrin Weidner, Michael Behnes, Marielen Reinhardt, et al.
Pageof 4